Effect of DODAB Nano-Sized Cationic Bilayer Fragments against Leishmania amazonensis
Abstract
:1. Introduction
2. Results
2.1. Electrophoretic Mobility of L. amazonensis Promastigotes after DODAB Treatment
2.2. Effect of DODAB in the Infective Forms of L. amazonensis
2.3. Loss of Intracellular Structures in L. amazonensis Parasites Treated with DODAB
2.4. DODAB Treatment Impairs L. amazonensis Proliferation in Macrophages
3. Discussion
4. Materials and Methods
4.1. Parasite Culture
4.2. Obtainment of Cationic Bilayers Fragments of Dioctadecyldimethylammonium Bromide (DODAB)
4.3. Parasite Treatment
4.4. Viability Assay
4.5. Transmission Electron Microscopy (TEM)
4.6. BMM Isolation
4.7. In Vitro Infection of BMMs with DODAB Pre-Treated Parasites
4.8. Statistical Analysis
Author Contributions
Funding
Conflicts of Interest
References
- Akhoundi, M.; Kuhls, K.; Cannet, A.; Votýpka, J.; Marty, P.; Delaunay, P.; Sereno, D. A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies. PLoS Negl. Trop. Dis. 2016, 10, e0004349. [Google Scholar] [CrossRef] [PubMed]
- Burza, S.; Croft, S.L.; Boelaert, M. Leishmaniasis. Lancet 2018, 392, 951–970. [Google Scholar] [CrossRef]
- WHO. Control of the Leishmaniases. In Proceedings of WHO Technical Report, Geneva, Switzerland, 22–26 March 2010. [Google Scholar]
- Kevric, I.; Cappel, M.A.; Keeling, J.H. New World and Old World Leishmania Infections: A Practical Review. Dermatol. Clin. 2015, 33, 579–593. [Google Scholar] [CrossRef] [PubMed]
- Uliana, S.R.B.; Trinconi, C.T.; Coelho, A.C. Chemotherapy of leishmaniasis: Present challenges. Parasitology 2018, 145, 464–480. [Google Scholar] [CrossRef] [PubMed]
- Ponte-Sucre, A.; Gamarro, F.; Dujardin, J.-C.; Barrett, M.P.; López-Vélez, R.; García-Hernández, R.; Pountain, A.W.; Mwenechanya, R.; Papadopoulou, B. Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl. Trop. Dis. 2017, 11, e0006052. [Google Scholar] [CrossRef]
- Alcântara, L.M.; Ferreira, T.C.S.; Gadelha, F.R.; Miguel, D.C. Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis. Int. J. Parasitol. Drugs Drug Resist. 2018, 8, 430–439. [Google Scholar] [CrossRef] [PubMed]
- Jones, N.G.; Catta-Preta, C.M.C.; Lima, A.P.C.A.; Mottram, J.C. Genetically Validated Drug Targets in Leishmania: Current Knowledge and Future Prospects. ACS Infect. Dis. 2018, 4, 467–477. [Google Scholar] [CrossRef] [Green Version]
- Hubert, D.H.W.; Jung, M.; Frederik, P.M.; Bomans, P.H.H.; Meuldijk, J.; German, A.L. Morphology Transformations of DODAB Vesicles Reminiscent of Endocytosis and Vesicular Traffic †. Langmuir 2000, 16, 8973–8979. [Google Scholar] [CrossRef]
- Carmona-Ribeiro, A. Bilayer-Forming Synthetic Lipids: Drugs or Carriers? Curr. Med. Chem. 2003, 10, 2425–2446. [Google Scholar] [CrossRef]
- Carmona-Ribeiro, A.M. Biomimetic Lipid Polymer Nanoparticles for Drug Delivery. Methods Mol. Biol. 2020, 2118, 45–60. [Google Scholar]
- Li, P.; Li, D.; Zhang, L.; Li, G.; Wang, E. Cationic lipid bilayer coated gold nanoparticles-mediated transfection of mammalian cells. Biomaterials 2008, 29, 3617–3624. [Google Scholar] [CrossRef] [PubMed]
- Barreleiro, P.C.A.; May, R.P.; Lindman, B. Mechanism of formation of DNA–cationic vesicle complexes. Faraday Discuss. 2003, 122, 191–201. [Google Scholar] [CrossRef] [PubMed]
- Lincopan, N.; Espíndola, N.M.; Vaz, A.J.; da Costa, M.H.B.; Faquim-Mauro, E.; Carmona-Ribeiro, A.M. Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo. Vaccine 2009, 27, 5760–5771. [Google Scholar] [CrossRef] [PubMed]
- Lincopan, N.; Santana, M.R.; Faquim-Mauro, E.; da Costa, M.; Carmona-Ribeiro, A.M. Silica-based cationic bilayers as immunoadjuvants. BMC Biotechnol. 2009, 9, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Campanhã, M.T.; Mamizuka, E.M.; Carmona-Ribeiro, A.M. Interactions Between Cationic Liposomes and Bacteria: The Physical-Chemistry of the Bactericidal Action. J Lipid Res. 1999, 4, 1495–1500. [Google Scholar]
- Campanhã, M.T.N.; Mamizuka, E.M.; Carmona-Ribeiro, A.M. Interactions between cationic vesicles and Candida albicans. J. Phys. Chem. B 2001, 105, 8230–8236. [Google Scholar] [CrossRef]
- Carmona-Ribeiro, A.M.; Ortis, F.; Schumacher, R.I.; Armelin, M.C.S. Interactions between cationic vesicles and cultured mammalian cells. Langmuir 1997, 13, 2215–2218. [Google Scholar] [CrossRef]
- Lincopan, N.; Mamizuka, E.M.; Carmona-Ribeiro, A.M. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments. J. Antimicrob. Chemother. 2005, 55, 727–734. [Google Scholar] [CrossRef] [PubMed]
- Carmona-Ribeiro, A. Biomimetic nanoparticles: Preparation, characterization and biomedical applications. Int. J. Nanomedicine 2010, 249. [Google Scholar] [CrossRef] [Green Version]
- Lincopan, N.; Borelli, P.; Fock, R.; Mamizuka, E.M.; Carmona-Ribeiro, A.M. Toxicity of an effective amphotericin B formulation at high cationic lipid to drug molar ratio. Exp. Toxicol. Pathol. 2006, 58, 175–183. [Google Scholar] [CrossRef]
- Vieira, D.B.; Carmona-Ribeiro, A.M. Cationic lipids and surfactants as antifungal agents: Mode of action. J. Antimicrob. Chemother. 2006, 58, 760–767. [Google Scholar] [CrossRef]
- Yamamoto, E.S.; Campos, B.L.S.; Jesus, J.A.; Laurenti, M.D.; Ribeiro, S.P.; Kallás, E.G.; Rafael-Fernandes, M.; Santos-Gomes, G.; Silva, M.S.; Sessa, D.P.; et al. The effect of ursolic acid on Leishmania (Leishmania) amazonensis is related to programed cell death and presents therapeutic potential in experimental cutaneous leishmaniasis. PLoS ONE 2015, 10, e0144946. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Castelani, L.; Arcaro, J.R.P.; Braga, J.E.P.; Bosso, A.S.; Moura, Q.; Esposito, F.; Sauter, I.P.; Cortez, M.; Lincopan, N. Short communication: Activity of nisin, lipid bilayer fragments and cationic nisin-lipid nanoparticles against multidrug-resistant Staphylococcus spp. isolated from bovine mastitis. J. Dairy Sci. 2019, 102, 678–683. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- De Almeida, A.F.; De Gaspari, E. Dioctadecyldimethylammonium bromide (DODAB-BF) as a new adjuvant for maternal-fetal immunization in mice against Neisseria meningitidis: Evaluation of humoral response. Pathog. Dis. 2018, 76. [Google Scholar] [CrossRef] [Green Version]
- De Melo Carrasco, L.D.; Sampaio, J.L.M.; Carmona-Ribeiro, A.M. Supramolecular cationic assemblies against multidrug-resistant microorganisms: Activity and mechanism of action. Int. J. Mol. Sci. 2015, 16, 6337–6352. [Google Scholar]
- Rozenfeld, J.H.K.; Silva, S.R.; Ranéia, P.A.; Faquim-Mauro, E.; Carmona-Ribeiro, A.M. Stable assemblies of cationic bilayer fragments and CpG oligonucleotide with enhanced immunoadjuvant activity in vivo. J. Control. Release 2012, 160, 367–373. [Google Scholar] [CrossRef] [PubMed]
- Aragão Horoiwa, T.; Cortez, M.; Sauter, I.P.; Migotto, A.; Bandeira, C.L.; Cerize, N.N.P.; de Oliveira, A.M. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation. Eur. J. Pharm. Sci. 2020, 147, 105295. [Google Scholar] [CrossRef] [PubMed]
- Sunter, J.; Gull, K. Shape, form, function and Leishmania pathogenicity: From textbook descriptions to biological understanding. Open Biol. 2017, 7, 170165. [Google Scholar] [CrossRef] [Green Version]
- Naderer, T.; Vince, J.E.; McConville, M.J. Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Curr. Mol. Med. 2004, 4, 649–665. [Google Scholar] [CrossRef]
- Mule, S.N.; Saad, J.S.; Fernandes, L.R.; Stolf, B.S.; Cortez, M.; Palmisano, G. Protein glycosylation in Leishmania spp. Mol. Omi. 2020. [Google Scholar] [CrossRef]
- Souto-Padron, T. The surface charge of trypanosomatids. An. Acad. Bras. Cienc. 2002, 74, 649–675. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saraiva, E.M.; Vannier-Santos, M.A.; Silva-Filho, F.C.; de Souza, W. Anionic site behavior in Leishmania and its role in the parasite-macrophage interaction. J. Cell Sci. 1989, 93 (Pt 3), 481–489. [Google Scholar]
- Eggimann, G.; Sweeney, K.; Bolt, H.; Rozatian, N.; Cobb, S.; Denny, P. The role of phosphoglycans in the susceptibility of Leishmania mexicana to the temporin family of anti-microbial peptides. Molecules 2015, 20, 2775–2785. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pimenta, P.F.P.; de Souza, W. Leishmania mexicana amazonensis: Surface charge of amastigote and promastigote forms. Exp. Parasitol. 1983, 56, 194–206. [Google Scholar] [CrossRef]
- Martins, L.M.S.; Mamizuka, E.M.; Carmona-Ribeiro, A.M. Cationic vesicles as bactericides. Langmuir 1997, 13, 5583–5587. [Google Scholar] [CrossRef]
- MORENO, S.N.J.; DOCAMPO, R. The role of acidocalcisomes in parasitic protists. J. Eukaryot. Microbiol. 2009, 56, 208–213. [Google Scholar] [CrossRef]
- Real, F.; Mortara, R.A. The diverse and dynamic nature of Leishmania parasitophorous vacuoles studied by multidimensional imaging. PLoS Negl. Trop. Dis. 2012, 6, e1518. [Google Scholar] [CrossRef] [Green Version]
- Soong, L. Subversion and utilization of host innate defense by Leishmania amazonensis. Front. Immunol. 2012, 3, 58. [Google Scholar] [CrossRef] [Green Version]
- Cortez, M.; Huynh, C.; Fernandes, M.C.; Kennedy, K.A.; Aderem, A.; Andrews, N.W. Leishmania promotes its own virulence by inducing expression of the host immune inhibitory ligand CD200. Cell Host Microbe 2011, 9, 463–471. [Google Scholar] [CrossRef] [Green Version]
- Sauter, I.P.; Madrid, K.G.; de Assis, J.B.; Sá-Nunes, A.; Torrecilhas, A.C.; Staquicini, D.I.; Pasqualini, R.; Arap, W.; Cortez, M. TLR9/MyD88/TRIF signaling activates host immune inhibitory CD200 in Leishmania infection. JCI Insight 2019, 4, e126207. [Google Scholar] [CrossRef]
- Alcântara, L.M.; Ferreira, T.C.S.; Fontana, V.; Chatelain, E.; Moraes, C.B.; Freitas-Junior, L.H. A Multi-species phenotypic screening assay for leishmaniasis drug discovery shows that active compounds display a high degree of species-specificity. Molecules 2020, 25, 2551. [Google Scholar] [CrossRef]
- Jiménez-Ruiz, A.; Alzate, J.F.; Macleod, E.T.; Lüder, C.G.K.; Fasel, N.; Hurd, H. Apoptotic markers in protozoan parasites. Parasit. Vectors 2010, 3, 104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Coelho, A.C.; Trinconi, C.T.; Senra, L.; Yokoyama-Yasunaka, J.K.U.; Uliana, S.R.B. Leishmania is not prone to develop resistance to tamoxifen. Int. J. Parasitol. Drugs Drug Resist. 2015, 5, 77–83. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Sample Availability: Samples of the compound DODAB are available from the authors. |
Cell Type | Cells/mL | EC50 [DODAB] | Reference |
---|---|---|---|
Mammalian cells | |||
Kidney epithelial cells | 105 | 5.4 mM | [19] |
3T3(cloneA31) fibroblasts | 104 | 1.0 mM | [18] |
SV40- SVT2 fibroblasts | 104 | 1.0 mM | [18] |
Gram-negative bacteria | |||
E. coli | 2 × 107 | 28 µM | [16] |
S. typhimurium | 2 × 107 | 10 µM | [16] |
P. aeruginosa | 3 × 107 | 5 µM | [16] |
Gram-positive bacteria | |||
S. aureus | 3 × 107 | 6 µM | [16] |
Yeasts | |||
C. albicans ATCC 90028 | 2 × 107 | 10 µM | [17] |
Protozoa | |||
Leishmania amazonensis * | 1 × 106 | 25 µM | This work. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ferreira, T.C.S.; Sauter, I.P.; Borda-Samper, L.; Bentivoglio, E.; DaMata, J.P.; Taniwaki, N.N.; Orrego, P.R.; Araya, J.E.; Lincopan, N.; Cortez, M. Effect of DODAB Nano-Sized Cationic Bilayer Fragments against Leishmania amazonensis. Molecules 2020, 25, 5741. https://doi.org/10.3390/molecules25235741
Ferreira TCS, Sauter IP, Borda-Samper L, Bentivoglio E, DaMata JP, Taniwaki NN, Orrego PR, Araya JE, Lincopan N, Cortez M. Effect of DODAB Nano-Sized Cationic Bilayer Fragments against Leishmania amazonensis. Molecules. 2020; 25(23):5741. https://doi.org/10.3390/molecules25235741
Chicago/Turabian StyleFerreira, Thalita C. S., Ismael P. Sauter, Lina Borda-Samper, Enyd Bentivoglio, Jarina P. DaMata, Noemi N. Taniwaki, Patrício R. Orrego, Jorge E. Araya, Nilton Lincopan, and Mauro Cortez. 2020. "Effect of DODAB Nano-Sized Cationic Bilayer Fragments against Leishmania amazonensis" Molecules 25, no. 23: 5741. https://doi.org/10.3390/molecules25235741